39 results
8-K
EX-99.1
CSBR
Champions Oncology, Inc.
11 Sep 24
Champions Oncology Reports Quarterly Revenue of $14.1 Million
4:34pm
-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo
8-K
EX-99.1
CSBR
Champions Oncology, Inc.
18 Jul 24
Champions Oncology Reports Quarterly Revenue of $14.0 Million
4:13pm
of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data
8-K
EX-99.1
gdynrlg wthilyb
12 Mar 24
Champions Oncology Reports Quarterly Revenue of $12.0 Million
4:31pm
8-K
EX-99.1
6pd8uzlqb9f1v
12 Dec 23
Champions Oncology Reports Quarterly Revenue of $11.6 Million
4:14pm
8-K
EX-99.1
6syr36ouh1f43
17 Oct 23
Champions Oncology Announces the Addition of Brady Davis as President
8:37am
8-K
EX-99.1
smv2bsrajf23 ihdxs0
13 Sep 23
Champions Oncology Reports Quarterly Revenue of $12.6 Million
4:00pm
8-K
EX-99.1
4gb3p6duo36b hnhiq
24 Jul 23
Champions Oncology Reports Quarterly Revenue of $13.1 Million
4:04pm
8-K
EX-99.1
qtid09
5 Apr 23
Champions Oncology Announces $5M Stock Repurchase Program
11:39am
8-K
EX-99.1
vqcdy9b9u8cvko
13 Dec 22
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
4:01pm
8-K
EX-99.1
x3fvslq96gnf
8 Sep 22
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
3:59pm